Deciphering direct transcriptional effects of epigenetic compounds through large-scale new RNA profiling
Open Access
- 18 July 2025
- journal article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 6629
Abstract
Examining direct transcriptional effects of genetic and chemical perturbations is crucial for understanding gene expression mechanisms. Standard RNA-seq experiments often overlook these direct effects, and current methods for profiling nascent RNA are usually time-consuming. Here, we adapted single-cell 4sU-based sequencing into a scalable, automated mini-bulk format to profile new RNA in smaller cell populations. This approach enabled us to map the direct transcriptional effects of epigenetic regulators. Brief exposure to SAHA (an HDAC inhibitor) revealed hundreds of directly responsive genes, many showing altered transcriptional bursting kinetics, with promoter regions enriched in binding sites for factors including bromodomain proteins. Profiling 83 epigenetic compounds uncovered direct transcriptional impacts from inhibitors of bromodomain proteins, histone deacetylases, and histone demethylases. Notably, chemically similar HDAC inhibitors elicited concordant direct responses and intronic expression analyses mirrored the direct effects seen in new RNA. This work highlights powerful approaches for investigating transcriptional mechanisms.Keywords
Funding Information
- Vetenskapsrådet
- Cancerfonden
- Torsten Söderbergs Stiftelse
This publication has 33 references indexed in Scilit:
- Chromatin proteins and modifications as drug targetsNature, 2013
- Precise Maps of RNA Polymerase Reveal How Promoters Direct Initiation and PausingScience, 2013
- Molecular mechanisms and potential functions of histone demethylasesNature Reviews Molecular Cell Biology, 2012
- Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drugNature Biotechnology, 2007
- The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and DiseaseScience, 2006
- Oncogenic PI3K deregulates transcription and translationNature Reviews Cancer, 2005
- CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTSAnnual Review of Pharmacology and Toxicology, 2005
- Molecular Evolution of the Histone Deacetylase Family: Functional Implications of Phylogenetic AnalysisJournal of Molecular Biology, 2004
- Histone Deacetylase InhibitorsJournal of Medicinal Chemistry, 2003
- Regulation of Transcription Factor YY1 by Acetylation and DeacetylationMolecular and Cellular Biology, 2001